Abstract
Allergenic immunotherapy consists of repeated administration of allergenic extracts to which an individual is allergic. It is currently the only treatment that modifies the course of allergic disease and induces short- as well as long-term remission of symptoms. Two formulations are currently available: subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT), with comparable efficacy. In specific situations, it can be used in combination with the new approved biologic therapies for asthma to improve tolerance of immunotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
